News

Vividion Therapeutics has secured worldwide rights for developing and commercialising VVD-214, the Werner helicase (WRN) ...
Regeneron and Sanofi’s blockbuster Dupixent has transformed the atopic dermatitis market, with future disruptors in the ...
The alert comes amid some patients accessing GLP-1RAs through unregulated channels, where safety information is often not ...
China’s NMPA has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, to treat persistent, recurrent or metastatic ...
Italy’s Axxam and Molecular Health have partnered to identify and validate new therapeutic targets in drug development.
AI is revolutionizing the pharma supply chain by automating manual tasks, monitoring risks and providing predictive insights.
Digital innovations such as ePRO and eCOA are streamlining clinical trials, boosting participant engagement, and improving ...